HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

H W Verspaget Selected Research

H W Verspaget Research Topics

Disease

7Neoplasms (Cancer)
07/2016 - 08/2000
6Stomach Neoplasms (Stomach Cancer)
07/2016 - 08/2000
5Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
09/2014 - 12/2002
4Colorectal Neoplasms (Colorectal Cancer)
02/2009 - 01/2000
4Crohn Disease (Crohn's Disease)
08/2007 - 12/2001
3Clostridium Infections
03/2021 - 12/2017
2Disease Susceptibility (Diathesis)
03/2009 - 09/2006
2Adenocarcinoma
02/2009 - 08/2000
2Ulcerative Colitis
08/2007 - 08/2005
2Inflammation (Inflammations)
08/2005 - 12/2002
2Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
10/2001 - 12/2000
1Melanoma (Melanoma, Malignant)
12/2022
1Rheumatoid Arthritis
01/2016
1Autoimmune Hepatitis
06/2015
1Colitis
09/2014
1Neuroendocrine Tumors (Neuroendocrine Tumor)
10/2011
1Carcinoid Tumor (Carcinoid)
10/2011
1Fibrosis (Cirrhosis)
08/2007
1Achlorhydria (Hypochlorhydria)
02/2006
1Typhoid Fever (Typhoid)
02/2006
1Fistula
09/2004
1Necrosis
09/2004
1Ischemia
12/2003
1Reperfusion Injury
12/2003
1Ovarian Neoplasms (Ovarian Cancer)
12/2000
1Ovarian Epithelial Carcinoma
12/2000
1Gastrointestinal Neoplasms (Gastrointestinal Cancer)
11/2000
1Metaplasia
11/2000
1Carcinoma (Carcinomatosis)
08/2000
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
08/2000
1Esophageal Neoplasms (Esophageal Cancer)
08/2000

Drug/Important Bio-Agent (IBA)

6Matrix Metalloproteinases (MMPs)IBA
04/2012 - 12/2003
4Proteins (Proteins, Gene)FDA Link
01/2016 - 08/2005
3AntioxidantsIBA
12/2002 - 08/2000
2Tissue Inhibitor of Metalloproteinase-1IBA
09/2006 - 04/2006
2EnzymesIBA
04/2006 - 08/2005
2ImmunosorbentsIBA
04/2006 - 08/2005
2Matrix Metalloproteinase 2 (Gelatinase A)IBA
04/2006 - 08/2005
2Infliximab (Remicade)FDA Link
09/2004 - 12/2001
2Superoxide DismutaseIBA
10/2001 - 08/2000
2MetallothioneinIBA
12/2000 - 11/2000
1Immune Checkpoint InhibitorsIBA
12/2022
1Biocompatible Materials (Biomaterials)IBA
07/2016
1AntibodiesIBA
01/2016
1HLA-DRB1*03:01 antigenIBA
06/2015
1HLA Antigens (Human Leukocyte Antigens)IBA
06/2015
1HLA-DRB1*04:01 antigenIBA
06/2015
1Toll-Like Receptor 6IBA
09/2014
1Conditioned Culture MediaIBA
01/2014
1Transforming Growth Factors (Transforming Growth Factor)IBA
01/2014
1Plasminogen Activator Inhibitor 1IBA
01/2014
1Peptide Hydrolases (Proteases)FDA Link
01/2014
1Peptides (Polypeptides)IBA
10/2011
1Bombesin Receptors (Bombesin Receptor)IBA
10/2011
1Gastrin-Releasing PeptideIBA
10/2011
1BombesinIBA
10/2011
1LigandsIBA
10/2011
1neuromedin BIBA
10/2011
1Interleukin-23 (Interleukin 23)IBA
03/2009
1NucleotidesIBA
03/2009
1Transcription Factors (Transcription Factor)IBA
02/2009
1Transforming Growth Factor beta1 (TGF beta 1)IBA
08/2007
1Tissue Inhibitor of MetalloproteinasesIBA
08/2007
1Matrix Metalloproteinase 1 (Interstitial Collagenase)IBA
08/2007
1Peroxidase (Myeloperoxidase)IBA
08/2007
1Matrix Metalloproteinase 7 (Matrilysin)IBA
07/2007
1AntigensIBA
09/2006
1Immunoglobulin G (IgG)IBA
02/2006
1Immunoglobulin A (IgA)IBA
02/2006
1GastrinsIBA
02/2006
1Matrix Metalloproteinase 9 (Gelatinase B)IBA
08/2005
1Messenger RNA (mRNA)IBA
08/2005
1Fibroblast Growth Factors (Fibroblast Growth Factor)IBA
09/2004
1Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
09/2004
1Oxygen (Dioxygen)IBA
12/2002
1Superoxide Dismutase-1IBA
12/2000
1PlatinumIBA
12/2000
1MetalloproteinsIBA
11/2000
1Oxidants (Oxidizing Agents)IBA
08/2000
1ZincIBA
08/2000
1Superoxides (Superoxide)IBA
08/2000
1CopperIBA
08/2000
1Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
01/2000

Therapy/Procedure

4Therapeutics
12/2022 - 08/2000
3Fecal Microbiota Transplantation
12/2022 - 01/2019
1Transplantation
12/2017
1Neoadjuvant Therapy
07/2016
1Liver Transplantation
12/2003
1Drug Therapy (Chemotherapy)
12/2000
1Chemoprevention
01/2000